Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >API>Specialty drugs>Ophthalmic drugs>Caspofungin Acetate
Caspofungin Acetate
  • Caspofungin Acetate

Caspofungin Acetate NEW

Price $52 $77 $157
Package 5mg 10mg 25mg
Min. Order:
Supply Ability: 10g
Update Time: 2025-05-23

Product Details

Product Name: Caspofungin Acetate CAS No.: 179463-17-3
Purity: 99.9% Supply Ability: 10g
Release date: 2025/05/23

Product Introduction

Bioactivity

NameCaspofungin Acetate
DescriptionCaspofungin Acetate (MK 0991) is the acetate salt of an antimycotic echinocandin lipopeptide, semisynthetically derived from a fermentation product of the fungus Glarea lozoyensis. This agent is active against Aspergillus and Candida species.
In vitroCaspofungin acetate is the first in a new class of antifungals that inhibits the synthesis of beta (1, 3)-d-glucan, an essential component of the cell wall of filamentous fungi. Prior studies have shown in vitro activity of caspofungin acetate using the reference methods, broth microdilution or macrodilution, for antifungal susceptibility testing of Candida species established by the National Committee for Clinical Laboratory Standards 1997 guidelines against a variety of Candida species including Candida krusei. Although caspofungin acetate is only Food and Drug Administration-approved for the treatment of aspergillosis, there is information showing that many Candida species are susceptible. The minimal inhibitory concentration for 90% inhibition of Candida species by caspofungin acetate are as follows:C. albicans 0.5 μg/mL (range, 0.25-0.5), C. glabrata 1.0 μg/mL (range, 0.25-2.0), C. tropicalis 1.0 μg/mL (range, 0.25-1.0), C. parapsilosis 0.5 μg/mL (range, 0.25-1.0), and C. krusei 2.0 μg/mL (range, 0.5-2.0)
In vivoMice injected with caspofungin at vitreal concentrations from 0.41 to 4.1 μM cause no significant alterations in their ERG waveforms and their retinas have no detectable morphologic changes or loss of cells. At the vitreal concentration of 41 μM, caspofungin reduces the amplitudes of the a-waves, b-waves, and scotopic threshold responses of the ERG and also produces a decrease in the number of cells in the ganglion cell layer[4]. Caspofungin (8 mg/kg) or amphotericin B at 1 mg/kg given i.p. once daily for 7 days beginning at 30 h after infection resulted in 100% survival through day 28 relative to vehicle control treatment, which results in 100% mortality by day 11 after infectious challenge. Caspofungin reduces recovery of viable Candida from kidney and brain tissues compared to vehicle control treatment on day 5, when control burden peaked. Caspofungin-treated mice dosed with 2 mg/kg or greater have significantly lower brain burden than amphotericin-B-treated mice at day 5. Amphotericin B and caspofungin treatment reduce kidney fungal burden by 1.7 log CFU/g and 2.46 to 3.64 log CFU/g, respectively[5].
Storagekeep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility InformationDMSO : 83.3 mg/mL (68.65 mM), Sonication is recommended.
H2O : 100 mg/mL (82.41 mM), Sonication is recommended.
KeywordsMK-0991 diacetate | MK-0991 | MK0991 | L-743873 | L743873 | L-743872 diacetate | L-743872 | L743872 | Inhibitor | inhibit | fungal cell wall | Fungal | Caspofungin diacetate | Caspofungin Acetate | antifungal | Antibiotic | 1,3-beta-D-glucan synthesis
Inhibitors RelatedNeomycin sulfate | Dehydroacetic acid sodium | L-Lactic acid | Potassium gluconate | Ampicillin sodium | Doxycycline (hyclate) | Kanamycin sulfate | Sulfamethoxazole sodium | Metronidazole | Doxycycline | Geraniol | EDTA copper(II) disodium salt
Related Compound LibrariesMacrocyclic Compound Library | Bioactive Compound Library | Cyclic Peptide Library | Approved Drug Library | EMA Approved Drug Library | Anti-Fungal Compound Library | Drug Repurposing Compound Library | Inhibitor Library | FDA-Approved Drug Library | Immunology/Inflammation Compound Library | Bioactive Compounds Library Max | Anti-COVID-19 Compound Library

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$/
VIP5Y
RongNa Biotechnology Co.,Ltd
2025-04-29
$0.00/1KG
VIP3Y
Hebei Chuanghai Biotechnology Co., Ltd
2024-10-24
$0.00/1kg
VIP5Y
Hebei Yanxi Chemical Co., Ltd.
2023-11-13
$80.00/1kg
VIP2Y
Zibo Hangyu Biotechnology Development Co., Ltd
2023-11-01
$0.00/25kg
Shaanxi Haibo Biotechnology Co., Ltd
2023-09-04
$30.00/1kg
Henan Bao Enluo International TradeCo.,LTD
2023-08-10
$0.00/25KG
VIP5Y
Hebei Mujin Biotechnology Co.,Ltd
2023-05-19
$500.00/1KG
Wuhan Boyuan Import & Export Co., LTD
2023-02-16
$10.00/1g
Qiuxian Baitai New Material Co., LTD
2021-11-22
$15.00/1KG
Zhuozhou Wenxi import and Export Co., Ltd
2021-07-10
  • Since: 2011-01-07
  • Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY